Article info

Download PDFPDF
Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al

Authors

  1. Correspondence to Dr Sarah H Chung, Rheumatology, University of Washington, Seattle, WA 98195, USA; sarahhc{at}uw.edu
View Full Text

Citation

Chung SH, Wener M, Bays AM, et al
Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al

Publication history

  • Received June 10, 2021
  • Accepted June 15, 2021
  • First published August 2, 2021.
Online issue publication 
January 10, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.